Literature DB >> 12322784

Unrelated allogeneic bone marrow transplant in adrenoleukodystrophy using CD34+ stem cell selection.

Anupama Borker1, Lolie C Yu.   

Abstract

Adrenoleukodystrophy is an inherited disease characterized by progressive neurodegeneration with rapid deterioration to a vegetative state. Of the treatment modalities tried to date, BMT is the only one with the potential for cure. However, the high rate of morbidity and mortality associated with allogeneic transplant makes it necessary to try out novel measures to improve the outcome in these patients. We report here a case where we used CD34+ stem cell selection for allogeneic unrelated-donor BMT in a patient with adrenoleukodystrophy.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12322784     DOI： 10.1023/a:1019969820308

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN： 0885-7490            Impact factor:   3.584


  12 in total

Review 1.  Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome.

Authors:  W Krivit; P Aubourg; E Shapiro; C Peters
Journal:  Curr Opin Hematol       Date:  1999-11       Impact factor: 3.284

2.  The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.

Authors:  F Rosales; N Peylan-Ramu; G Cividalli; G Varadi; R Or; E Naparstek; S Slavin; A Nagler
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

3.  Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation.

Authors:  P Aubourg; S Blanche; I Jambaqué; F Rocchiccioli; G Kalifa; C Naud-Saudreau; M O Rolland; M Debré; J L Chaussain; C Griscelli
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

Review 4.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

Review 5.  Graft-versus-host disease.

Authors:  R P Gale
Journal:  Immunol Rev       Date:  1985-12       Impact factor: 12.988

6.  Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood.

Authors:  A Urbano-Ispizua; C Rozman; C Martínez; P Marín; J Briones; M Rovira; P Féliz; M C Viguria; A Merino; J Sierra; R Mazzara; E Carreras; E Montserrat
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

Review 7.  T cell depletion in bone marrow transplantation.

Authors:  C H Poynton
Journal:  Bone Marrow Transplant       Date:  1988-07       Impact factor: 5.483

8.  High dose immunoglobulin IV treatment in adrenoleukodystrophy.

Authors:  M Cappa; E Bertini; P del Balzo; P Cambiaso; A Di Biase; S Salvati
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

9.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

10.  Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.

Authors:  D J Loes; A E Stillman; S Hite; E Shapiro; L Lockman; R E Latchaw; H Moser; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825
View more
  1 in total

Review 1.  The Vegetative State and Stem Cells: Therapeutic Considerations.

Authors:  Alan S Hazell
Journal:  Front Neurol       Date:  2016-08-23       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.